The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000929303p
Ethics application status
Help: Ethics application status
Not yet submitted
Date submitted
Help: Date submitted
28/04/2026
Date registered
Help: Date registered
28/07/2026
Date last updated
Help: Date last updated
28/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
28/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Can Eye Movement Desensitisation and Reprocessing (EMDR) therapy work in public mental health services? A pilot study
Scientific title
Feasibility and acceptability of Eye Movement Desensitisation and Reprocessing (EMDR) therapy in public mental health services: A pilot study
Additional trial identifiers [1] 317125 0
nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Post traumatic stress disorder 341680 0
mental health 341681 0
trauma 341682 0
substance abuse 341683 0
Condition category
Condition code
Mental Health 337773 337773 0 0
Anxiety
Mental Health 337888 337888 0 0
Other mental health disorders
Public Health 337889 337889 0 0
Health service research

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
EMDR is a structured, Level 1 evidence-based treatment for PTSD and Complex PTSD (Australian Psychological Association, 2024). It follows an 8-phase standard protocol including assessment, resource building, memory mapping, and stabilisation, followed by trauma memory desensitisation and reprocessing. Resource building involves teaching distress tolerance and anxiety management skills, and is also referred to as the stabilisation phase in the trauma therapy research. Memory mapping the process of mapping a participant's traumatic memory networks chronologically to identify appropriate memories for processing. During the processing phase of EMDR therapy, participants will focus on an emotionally disturbing memory while simultaneously also focussing on a bilateral stimulus (such as lateral eye movements, tapping, or other cognitive tasks) until the level of disturbance is reduced. EMDR therapy appears to work by exposure to distressing memories paired with memory taxation which results in memory degradation. In this context, the participant learns to associate more adaptive memories and safety in the present, reduce emotional distress and promote adaptive learning. Participants will receive up to 16 weekly individual sessions of EMDR to focus on one traumatic memory, and will be asked not to engage with other psychological therapies for trauma for the duration of their EMDR therapy. They will continue to receive treatment as usual during the study including medication and case management.
EMDR treatment and protocol selection will be tailored to each participant by their assigned therapist. All EMDR therapists are mental health clinicians that have completed a minimum of approved accredited basic EMDR training (including 20 hours of didactic training, 20 hours of skills training and 10 hours of consultation with an Accredited Consultant) with the EMDR Association of Australia (EMDRAA) or the EMDR International Association (EMDRIA). EMDR therapists will attend monthly peer supervision facilitated by an EMDRAA Accredited Consultant. Consistent with previous research, EMDR participants will be offered up to 16 weekly sessions for 60 to 90 minutes duration determined by the clinical needs identified through ongoing therapist assessments (Bates et al, 2024; Gielkens et al, 2024). Sessions will be offered face-to-face or via telehealth, and delivered in a clinic environment or consumer's home (if appropriate). Consumers will be reminded of appointments and monitored weekly.
Intervention code [1] 333889 0
Treatment: Other
Intervention code [2] 333988 0
Behaviour
Description of the comparator or control
There is no control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345226 0
Acceptability
Timepoint [1] 345226 0
Within 1 week post-Intervention and 6-week follow-up
Primary outcome [2] 345227 0
Acceptability: attrition rates and reasons for withdrawal will be assessed as a composite outcome
Timepoint [2] 345227 0
Within 1 week post-Intervention
Primary outcome [3] 345371 0
Acceptability: safety
Timepoint [3] 345371 0
Within 1 week post-Intervention
Secondary outcome [1] 461001 0
safety: frequency and duration of emergency department presentations and inpatient admissions will be assessed as a composite outcome
Timepoint [1] 461001 0
6-weeks Pre-Intervention, At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [2] 461002 0
Feasibility: Distress
Timepoint [2] 461002 0
Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [3] 461003 0
Feasibility
Timepoint [3] 461003 0
Within 1 week post-Intervention
Secondary outcome [4] 461004 0
Feasibility: percentage of therapy completers
Timepoint [4] 461004 0
Within 1 week post-Intervention
Secondary outcome [5] 461005 0
Feasibility:
Timepoint [5] 461005 0
Within 1 week post-Intervention
Secondary outcome [6] 461006 0
Feasibility:
Timepoint [6] 461006 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [7] 461007 0
Presence and severity of post traumatic stress disorder symptoms in adult participants - this will be assessed as a composite outcome
Timepoint [7] 461007 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [8] 461008 0
Impact of mental health on daily functioning
Timepoint [8] 461008 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [9] 461009 0
level of dependence on a substance in adult participants
Timepoint [9] 461009 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [10] 461010 0
level of alcohol use in adult participants
Timepoint [10] 461010 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [11] 461453 0
Ability to perform activities of daily living in adult participants
Timepoint [11] 461453 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [12] 461454 0
overall level of social and daily functioning, physical and mental health symptoms in adult participants. this will be assessed as a composite outcome
Timepoint [12] 461454 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [13] 461455 0
severity of depression, anxiety and stress symptoms in child and youth participants. this will be assessed as a composite outcome
Timepoint [13] 461455 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [14] 464018 0
presence and severity of PTSD symptoms in child and youth participants. this will be assessed as a composite outcome
Timepoint [14] 464018 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [15] 464019 0
level of functioning across behavioural, social, mental health domains in child and youth participants. this will be assessed as a composite outcome
Timepoint [15] 464019 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up
Secondary outcome [16] 464020 0
overall level of impairment in child and youth participants
Timepoint [16] 464020 0
At the start of therapy (baseline), Within 1 week post-Intervention, 6-week follow-up

Eligibility
Key inclusion criteria
Consistent with recent research (Devadason, 2025), the specified inclusion criteria will be consumers who are current consumers of the MNMH, MNADPT and MSAMHS teams and:
• Are aged 15 years or older
• Have a primary or secondary ICD-11 diagnosis of PTSD, or other mental health disorder specifically associated with stress recorded in their clinical file
• Have a stable level of suicide or self-harm risk that has not been a focus of care in past three months as confirmed by their treating team.
• Psychotropic medications have been stable for at least 6 weeks
• Have stable accommodation
• Have English literacy skills greater than grade 4 as per years of education
• Have capacity to consent to the research as advised by their treating team
• Have not received EMDR for the traumatic memory they are currently seeking therapy to address.
• Are not currently receiving another psychological therapy for the traumatic incident
Minimum age
15 Years
Maximum age
65 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
The specified exclusion criteria will be consumers who:
• Have an Intellectual impairment or Acquired Brain Injury
• Older than 65 years
• Do not have a primary or secondary ICD-11 diagnosis of PTSD, or other mental health disorder specifically associated with stress
• Are currently involved in legal action regarding the traumatic incident
• Are in an acute crisis situation with heightened suicidality, self-harm risk or behaviours, or risk of harm to others as confirmed by their treating team
• Are in an acute phase of a psychotic illness
• Have a significant forensic history
• Have an untreated acute or debilitating medical condition
• Are currently an inpatient in a mental health unit

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis
This is a pilot study at assess the feasibility and acceptability of EMDR in public mental health services, not an effectiveness study. Consistent with previous research (eg Gielkens et al, 2024), and using Lewis et al's (2021) sample size calculation, a total sample of 30 participants will be recruited to detect a large effect size with 95 percent power at an alpha level of 0.05.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD
Recruitment hospital [1] 29739 0
Wynnum-Manly Community Health Centre - Wynnum West
Recruitment hospital [2] 29740 0
Logan Central Community Health Centre - Logan Central
Recruitment hospital [3] 29741 0
Princess Alexandra Hospital - Woolloongabba
Recruitment hospital [4] 29742 0
The Prince Charles Hospital - Chermside
Recruitment hospital [5] 29743 0
Biala City Community Health Centre - Brisbane
Recruitment hospital [6] 29744 0
Inala Community Health Centre - Inala
Recruitment hospital [7] 29745 0
Browns Plains Community Health Centre - Hillcrest
Recruitment hospital [8] 29746 0
Chermside Community Health Centre - Chermside
Recruitment hospital [9] 29747 0
Redcliffe Hospital - Redcliffe
Recruitment postcode(s) [1] 46086 0
4178 - Wynnum West
Recruitment postcode(s) [2] 46087 0
4114 - Logan Central
Recruitment postcode(s) [3] 46088 0
4102 - Woolloongabba
Recruitment postcode(s) [4] 46089 0
4032 - Chermside
Recruitment postcode(s) [5] 46090 0
4000 - Brisbane
Recruitment postcode(s) [6] 46091 0
4077 - Inala
Recruitment postcode(s) [7] 46092 0
4118 - Hillcrest
Recruitment postcode(s) [8] 46093 0
4020 - Redcliffe

Funding & Sponsors
Funding source category [1] 321709 0
Government body
Name [1] 321709 0
Metro South Addiction and Mental Health Service
Country [1] 321709 0
Australia
Funding source category [2] 321823 0
Government body
Name [2] 321823 0
Metro North Mental Health Service
Country [2] 321823 0
Australia
Primary sponsor type
Individual
Name
Victoria Gore-Jones, Metro South Addiction and Mental health Service
Address
Country
Australia
Secondary sponsor category [1] 324537 0
Individual
Name [1] 324537 0
Anthony Bligh, Metro north mental health service
Address [1] 324537 0
Country [1] 324537 0
Australia

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 320241 0
Metro South Human Research Ethics Committee
Ethics committee address [1] 320241 0
Ethics committee country [1] 320241 0
Australia
Date submitted for ethics approval [1] 320241 0
31/07/2026
Approval date [1] 320241 0
Ethics approval number [1] 320241 0
Ethics committee name [2] 320244 0
Metro North Health Human Research Ethics Committee
Ethics committee address [2] 320244 0
Ethics committee country [2] 320244 0
Australia
Date submitted for ethics approval [2] 320244 0
15/08/2026
Approval date [2] 320244 0
Ethics approval number [2] 320244 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 149862 0
Ms Victoria Gore-Jones
Address 149862 0
Metro South Addiction and Mental Health Service, 228 Logan Road, Woolloongabba, QLD 4102
Country 149862 0
Australia
Phone 149862 0
+61 0403773044
Fax 149862 0
Email 149862 0
Contact person for public queries
Name 149863 0
Victoria Gore-Jones
Address 149863 0
Metro South Addiction and Mental Health Service, 228 Logan Road, Woolloongabba, QLD 4102
Country 149863 0
Australia
Phone 149863 0
+61 0403773044
Fax 149863 0
Email 149863 0
Contact person for scientific queries
Name 149864 0
Victoria Gore-Jones
Address 149864 0
Metro South Addiction and Mental Health Service, 228 Logan Road, Woolloongabba, QLD 4102
Country 149864 0
Australia
Phone 149864 0
+61 0403773044
Fax 149864 0
Email 149864 0

Data sharing statement
Will the study consider sharing individual participant data?
No
No IPD sharing reason/comment: No individual data will be reported. Only aggregated results will be reported.



What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Informed consent form    EMDR PICF v1.4 160626 (3).docx
Study protocol    EMDR Feasibility Study Protocol 220726.pdf


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.